🔬 Better data. Better understanding. Better outcomes.
🤝 Together with partners like Trajan Scientific and Medical, #HIPPOCRATES_IMI is working towards improving outcomes for people with #PsoriaticArthritis.
Learn more 🔗 hippocrates-imi.eu
#Psoriasis #Biomarkers #PrecisionMedicine #Collaboration
❔ What is it like to contribute to a large-scale European research initiative early in your career? Discover the answer & get to know some of the early-career researchers behind #HIPPOCRATES_IMI!
Find the full series on our website 🔗 lnkd.in/d4vmrDaf
#Psoriasis #EarlyCareerResearchers #EUResearch
🌍 On #WorldHealthDay we join the call to #StandWithScience.
🔬 At #HIPPOCRATES_IMI, we believe better health outcomes come from strong science and collaboration between researchers, industry & patients across Europe.
🤝 Real progress happens when science, expertise & lived experience come together.
📽️ Spotlight on Early-Career Researchers in #HIPPOCRATES_IMI 👨🔬
Today on #WorldHealthDay Sudharshan Rao highlights how improving health starts when science, expertise, & lived experience come together.
🔗 youtu.be/S7Tj6BuDOxM
#PsoriaticArthritis #StandWithScience #EUResearch
📅 #HIPPOCRATES_IMI member Laura Coates will present at Dermatology Academy 2026.
Don’t miss this opportunity to gain insights from the HPOS study & Laura Coates’ work in HIPPOCRATES!
Register 👉 www.rheumatologyevents.org/event/dermat...
#ProriaticArthritis #Psoriasis #Dermatology #Rheumatology
📽️ Spotlight on the Early-Career Researchers in HIPPOCRATES 🧑🔬
Next in our interview series is @hilllary.bsky.social.
Watch the video and gain more insights into the research on psoriatic arthritis in #HIPPOCRATES_IMI.
🔗 youtu.be/ztyXOiEhahw
#Psoriasis #PsoriaticArthritis #EUResearch
✨Get ready for the EULAR 2026 Congress in London.
💡To make your travel smooth and your experience unforgettable, we’ve put together 4 simple steps to help you plan ahead: from registration to hotel booking and more.
🚀Make the most of your time. Are you ready for June?
#eularCongress
📢 New publication on the HPOS #study protocol now available!
The article discusses:
🔎 Study objectives & design
🤝 Impact of #PRPs on study development
🌍 Recruitment strategies & challenges
Full article 🔗 journals.sagepub.com/doi/10.1177/...
More on HPOS 👉 hpos.study
#Psoriasis #PsoriaticArthritis
📽️ Spotlight on the Early-Career Researchers in HIPPOCRATES 👩🔬
We kick off our interview series with Patricia Riedlova.
Watch the video and gain a closer look at the day-to-day work of a researcher in #HIPPOCRATES_IMI
🔗 youtu.be/acTX16l1MQA
#Psoriasis #PsoriaticArthritis #EUResearch
Today is #InternationalDayofWomenandGirlsInScience and we want to use this occasion to highlight some of the young female researchers working in #HIPPOCRATES_IMI.
👉 Visit our website to meet the young female researchers & learn about their views & experiences! 🔗 hippocrates-imi.eu/news/interna...
Europaweite Studie für Menschen mit #Schuppenflechte! 🧬
Das Projekt #HPOS (Teil von #HIPPOCRATES) untersucht, wer ein Risiko für #PsoriasisArthritis hat – mit Patienten und Patientinnen als Forschungspartnern.
Jetzt teilnehmen: hpos.study
📄 We're pleased to share a new #HIPPOCRATES_IMI #publication!
The review explores how we can better define, detect, and measure the transition from #psoriasis to #psoriaticarthritis – and when preventive intervention should begin.
Read the full article 🔗 authors.elsevier.com/c/1mUy59UBHv...
✨ Welcome 2026!
#HIPPOCRATES_IMI looks forward to another year of collaboration & progress in advancing research & developing innovative personalised treatment strategies for #PsoriaticArthritis.
Here’s to new milestones & shared impact in the year ahead!
#HappyNewYear #Rheumatology #EUResearch
As the year comes to an end, we’re reflecting on the progress made and the next steps toward advancing research for #PsoriaticArthritis. The #HIPPOCRATES_IMI team is excited for what 2026 will bring.
Wishing you HIPPO Holidays and a joyful New Year! 💫
📄 New #LaySummary
#PsoriaticArthritis affects around 30% of people with psoriasis & often remains difficult to diagnose & treat. Learn about how #HIPPOCRATES_IMI aims to change this.
📊 View the graphical abstract
🔗 Visit our website to read the full lay summary:
hippocrates-imi.eu/publications...
#HIPPOCRATES_IMI at the Spondyloarthritis Golden Anniversary Meeting 👏
At the Leeds meeting in late November, Oliver FitzGerald presented key achievements made in HIPPOCRATES so far, including advances in clinical & molecular data collection.
#PsoriaticArthritis #PsA #Rheumatology #EUResearch
Last week, at the @eular.org PARE Conference 2025 in Brussels, our patient research partners – Maarten de Wit, Souzi Makri, Elsa Mateus, Wendy Wagenaar & Heidi Bertheussen – together with Diana Rodrigues and Hillary Collins, represented #HIPPOCRATES_IMI with a case study and two posters.
🎓 Discover the new “How to Treat” session from EULAR Congress 2025 meets Education!
Join Dr. Laura Coates in Psoriatic Arthritis, now an interactive module, and explore new therapies, clinical updates, and strategies to improve outcomes.
Start for free now 👉 https://pulse.ly/akuflks821
Do you have #Psoriasis, live in Europe, and are 18 or older?
Then check out the #HPOS study and help advance research into #PsoriaticArthritis across Europe!
Learn more 🔗 hpos.study
#HIPPOCRATES_IMI #EUResearch
📰NEWS ALERT!
#EULAR has released new consensus definitions and points to consider to help identify and manage psoriatic arthritis (PsA).
📖Read the full #eularPressRelease here 👉https://pulse.ly/bkctzh20ad
#PsA #Rheumatology #PatientCare
🌍 Today is #WorldPsoriasisDay!
1️⃣ in 3️⃣ people with #Psoriasis develop #PsoriaticArthritis. The #HIPPOCRATES_IMI HPOS study aims to identify those at risk.
📈 Update on #HPOS: 5,225 participants recruited in 8 countries! And we are still looking to reach the target of 25,000.
Join us 🔗 hpos.study
🌍 This week marks #WorldPsoriasisDay!
Psoriatic disease is more than a skin condition! This year's theme highlights the comorbidities linked to psoriatic disease and the domino effect on overall health.
💬 Join the campaign & share your story: lnkd.in/e23mD5ZM
#StopTheDominoEffect #Hippocrates_IMI
We’re excited to share that #HIPPOCRATES_IMI is featured in the latest EULAR Research Newsletter! 📨
💡Stay updated on research advancing understanding of RA and RMDs. Subscribe here 🔗 www.eular.org/research-new...
#PsoriaticArthritis #Rheumatology #EUResearch
Yesterday was #WAD2025, celebrating the power of dreams!
For people living with RMDs, dreams bring strength and motivation. We are proud to partner with @eular.org and share the dreams of our #PatientResearchPartners in HIPPOCRATES with you.
💭 What are your #RMDreams?
Explore the #RMDreams word cloud, showcasing the hopes and aspirations of people living with RMDs.
💬 Share your dream in the comments and help create a more supportive world!
👉 Learn how to get involved in #WorldArthritisDay: https://pulse.ly/ymrma6knf1
#EULAR #WAD2025
📅 Save the Date!
Join the EULAR Communities webinar for #WAD2025: Achieve Your Dreams.
Hear inspiring stories and practical tips to help you live your best life.
👉 Register here: https://pulse.ly/xvnmonsftf
#RMDreams #WorldArthritisDay #EULAR
Over 120M Europeans live with RMDs - an often invisible disease. Together, let's raise awareness on #WorldArthritisDay which is celebrated every year on 12 October.
👉 Learn more: https://pulse.ly/qaxqte5wdk
#WAD2025 #EULAR #RMDreams
📆 Last week the HIPPOCRATES consortium came together for their fourth Annual Plenary Meeting.
The meeting included a Sustainability Workshop & as every year closed with the HIPPO award ceremony. 🎉
Read more 🔗 hippocrates-imi.eu/news/fourth-...
#PsoriaticArthritis #Rheumatology #EUResearch
HIPPOCRATES is part of #ChronicConditions2025!
We’re excited to share that HIPPOCRATES and the HPOS study have been featured in an article highlighting Psoriasis, PsA risks and underdiagnosis.
🔗 Read the article: www.healthnews.ie/chronic-cond...
#PsoriaticArthritis #Rheumatology
HIPPOCRATES has reconvened for the Annual Plenary Meeting & General Assembly in Amsterdam! 🤝
Day 1 featured flash talks from early-stage researchers, insights from our PRPs, and an inspiring keynote by Geert D'Haens on the future of IMID management.
Looking forward to more discussions today! 💬
